AURA — Aura Biosciences, Inc. stock price, charts and financials

QT41Aura Biosciences, Inc.

Aura Biosciences, Inc. (NASDAQ: AURA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
7.15
+0.11+1.56%
OverviewShort InterestFilings
AURAQT41Aura Biosciences, Inc.·NASDAQ
7.15+1.56%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 20263Initial statement of beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 2026DEF 14ADefinitive proxy statement
Jun 17, 2026PRE 14APreliminary proxy statement
Jun 16, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
May 19, 20264Statement of changes in beneficial ownership
May 19, 2026S-8Registration of employee benefit securities
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 11, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
May 11, 20264Statement of changes in beneficial ownership
May 07, 20263Initial statement of beneficial ownership
May 05, 20268-KCurrent report
May 05, 2026424B5Prospectus
May 04, 2026DEFA14AAdditional proxy soliciting materials
May 04, 2026S-3MEFS-3MEF
#1 / 25 of 346
Page
▼
/ 14